MedTrace Logo

HFNC in Management of Bronchiectasis Exacerbation

NCT05741697 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-04-30

No results posted yet for this study

Summary

Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).

Conditions

Interventions

DRUG

bi-level ventillation

non-invasive mechanical ventilation

Sponsors & Collaborators

  • WGEKHALEEL

    collaborator UNKNOWN

  • AARMHUSSIEN

    collaborator UNKNOWN

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmad M. Shaddad · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2026-08-01
Completion
2026-10-01
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741697 on ClinicalTrials.gov